AbbVie Inc. (FRA:4AB)
Germany
· Delayed Price · Currency is EUR 161.00
+1.00 (0.63%)
At close: May 23, 2025, 10:00 PM CET
AbbVie Employees
AbbVie had 55,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.00% compared to the previous year.
Employees
55,000
Change (1Y)
5,000
Growth (1Y)
10.00%
Revenue / Employee
€965,017
Profits / Employee
€69,895
Market Cap
285.61B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| SAP SE | 109,121 |
| Siemens Aktiengesellschaft | 327,000 |
| Deutsche Telekom AG | 198,194 |
| Allianz SE | 156,626 |
| Rheinmetall AG | 28,539 |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 44,224 |
| Siemens Energy AG | 98,000 |
| Siemens Healthineers AG | 72,000 |
AbbVie News
- 4 days ago - 69 May Aristocrats: Buy 1 Of 38 "Safer" Dividend Dogs - Seeking Alpha
- 5 days ago - Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV - PRNewsWire
- 5 days ago - Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc. (ABBV) Shareholders - GlobeNewsWire
- 5 days ago - Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) should contact The Gross Law Firm about pending Class Action - ABBV - PRNewsWire
- 6 days ago - Shareholders That Lost Money on Cerevel Therapeutics Holdings, Inc.(ABBV) Should Contact Levi & Korsinsky about Pending Class Action - ABBV - Accesswire
- 8 days ago - Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of June 3, 2025 in Cerevel Therapeutics Holdings, Inc. Lawsuit – ABBV - GlobeNewsWire
- 8 days ago - 3 Stocks That Will Profit From Trump's Drug Price Cut - Benzinga
- 9 days ago - Is It Time To Buy AbbVie Stock At $180? - Forbes